We are live on ! Find out more
IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
-7.62%
1 Year Est. Return
+17.25%
3 Year Est. Return
+11.14%
5 Year Est. Return
+79.35%
10 Year Est. Return
–
AUM
$297M
AUM Growth
-$31.7M
Cap. Flow
-$5.36M
Cap. Flow %
-1.8%
Top 10 Hldgs %
47.78%
Holding
70
New
9
Increased
18
Reduced
13
Closed
5

Top Buys

1
QURE icon
uniQure
QURE
+$11M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$8.45M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$8.21M
4
BIIB icon
Biogen
BIIB
+$7.81M
5
GILD icon
Gilead Sciences
GILD
+$6.85M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.3M
2
APLS
Apellis Pharmaceuticals
APLS
+$11.8M
3
AMGN icon
Amgen
AMGN
+$9.48M
4
HRMY icon
Harmony Biosciences
HRMY
+$8.89M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.55M

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
51
Insmed
INSM
$23.8B
$1.01M 0.34%
40,100
– –
BPMC
52
DELISTED
Blueprint Medicines
BPMC
$1M 0.34%
+20,000
New +$1.07M
AKRO
53
DELISTED
Akero Therapeutics
AKRO
$935K 0.32%
18,489
-60,000
-76% -$2.79M
KZR
54
DELISTED
Kezar Life Sciences
KZR
$831K 0.28%
+70,383
New +$1.25M
NTLA icon
55
Intellia Therapeutics
NTLA
$1.82B
$758K 0.26%
24,000
– –
PRTA icon
56
Prothena Corp
PRTA
$441M
$723K 0.24%
+15,000
New +$891K
AGIO icon
57
Agios Pharmaceuticals
AGIO
$2.37B
$594K 0.2%
24,000
– –
BEAM icon
58
Beam Therapeutics
BEAM
$3.17B
$565K 0.19%
23,500
– –
VTYX
59
DELISTED
Ventyx Biosciences
VTYX
$521K 0.18%
15,000
– –
VIR icon
60
Vir Biotechnology
VIR
$1.62B
$440K 0.15%
+47,000
New +$670K
NBP
61
NovaBridge Biosciences American Depositary Shares
NBP
$214M
$410K 0.14%
310,499
– –
PTCT icon
62
PTC Therapeutics
PTCT
$6.54B
$381K 0.13%
17,000
– –
ARVN icon
63
Arvinas
ARVN
$534M
$334K 0.11%
17,000
– –
PTGX icon
64
Protagonist Therapeutics
PTGX
$8.71B
$332K 0.11%
19,900
– –
RLMD icon
65
Relmada Therapeutics
RLMD
$652M
$30K 0.01%
10,000
– –
APLS
66
DELISTED
Apellis Pharmaceuticals
APLS
– –
-129,700
Closed -$11.8M
HCM icon
67
HUTCHMED
HCM
$1.99B
– –
-68,000
Closed -$816K
SAGE
68
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
Closed -$939K
TVTX icon
69
Travere Therapeutics
TVTX
$5.28B
– –
-441,019
Closed -$6.77M
HZNP
70
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-67,000
Closed -$6.89M
1 2
3

Similar funds

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
KBC
Key Bridge Compliance $319M AUM